Kaveri Pohlman
Stock Analyst at Clear Street
(2.66)
# 2,156
Out of 5,124 analysts
34
Total ratings
32.26%
Success rate
2.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Downgrades: Hold | $60 → $58 | $57.69 | +0.54% | 3 | Jan 20, 2026 | |
| JANX Janux Therapeutics | Downgrades: Hold | $32 → $12 | $13.07 | -8.19% | 3 | Jan 20, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $12 | $1.64 | +631.71% | 1 | Dec 30, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $61 → $99 | $74.92 | +32.14% | 1 | Dec 9, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $200 | $82.20 | +143.31% | 1 | Dec 5, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $15.32 | +63.19% | 1 | Nov 25, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $11 → $21 | $11.45 | +83.49% | 1 | Nov 14, 2025 | |
| ZURA Zura Bio | Initiates: Buy | $18 | $6.01 | +199.50% | 1 | Nov 13, 2025 | |
| SGMT Sagimet Biosciences | Initiates: Buy | $29 | $5.55 | +422.52% | 1 | Oct 22, 2025 | |
| VTYX Ventyx Biosciences | Initiates: Buy | $11 | $13.96 | -21.20% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $33.05 | +39.18% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $21.86 | +46.39% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.81 | - | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $47 | $30.90 | +52.10% | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $30 | $12.23 | +145.30% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $38 | $11.61 | +227.30% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $5.70 | -12.28% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.51 | +429.80% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $43.90 | -38.50% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $21.03 | +232.86% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.77 | +218.30% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $5.67 | +41.09% | 2 | Jul 7, 2022 |
RAPT Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $60 → $58
Current: $57.69
Upside: +0.54%
Janux Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $32 → $12
Current: $13.07
Upside: -8.19%
Palisade Bio
Dec 30, 2025
Initiates: Buy
Price Target: $12
Current: $1.64
Upside: +631.71%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $61 → $99
Current: $74.92
Upside: +32.14%
Palvella Therapeutics
Dec 5, 2025
Initiates: Buy
Price Target: $200
Current: $82.20
Upside: +143.31%
Jade Biosciences
Nov 25, 2025
Initiates: Buy
Price Target: $25
Current: $15.32
Upside: +63.19%
Trevi Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $11 → $21
Current: $11.45
Upside: +83.49%
Zura Bio
Nov 13, 2025
Initiates: Buy
Price Target: $18
Current: $6.01
Upside: +199.50%
Sagimet Biosciences
Oct 22, 2025
Initiates: Buy
Price Target: $29
Current: $5.55
Upside: +422.52%
Ventyx Biosciences
Oct 1, 2025
Initiates: Buy
Price Target: $11
Current: $13.96
Upside: -21.20%
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $33.05
Upside: +39.18%
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $21.86
Upside: +46.39%
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.81
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $30.90
Upside: +52.10%
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $12.23
Upside: +145.30%
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $11.61
Upside: +227.30%
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $5.70
Upside: -12.28%
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.51
Upside: +429.80%
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $43.90
Upside: -38.50%
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $21.03
Upside: +232.86%
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $3.77
Upside: +218.30%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $5.67
Upside: +41.09%